Veterinary Medicines

GLUCOSE BIOPHARM 40%

Authorised
  • Glucose monohydrate
Download as PDF

Product identification

Medicine name:
ГЛЮКОЗА БИОФАРМ 40%
GLUCOSE BIOPHARM 40%
Active substance:
  • Glucose monohydrate
Target species:
  • Cattle
  • Horse
  • Sheep
  • Goat
  • Pig
  • Dog
  • Cat
Route of administration:
  • Intravenous use

Product details

Active substance and strength:
  • Glucose monohydrate
    44.00
    gram(s)
    /
    100.00
    millilitre(s)
Pharmaceutical form:
  • Solution for infusion
Withdrawal period by route of administration:
  • Intravenous use
    • Cattle
      • Milk
        0
        day
      • Meat and offal
        0
        day
    • Horse
      • Meat and offal
        0
        day
    • Sheep
      • Milk
        0
        day
      • Meat and offal
        0
        day
    • Goat
      • Milk
        0
        day
      • Meat and offal
        0
        day
    • Pig
      • Meat and offal
        0
        day
    • Dog
    • Cat
Anatomical therapeutic chemical veterinary (ATCvet) codes:
  • QB05BA03
Legal status of supply:
  • Veterinary medicinal product subject to veterinary prescription
Authorisation status:
  • Valid
Authorised in:
  • Bulgaria
Package description:

Additional information

Entitlement type:
  • Marketing Authorisation
Legal basis of product authorisation:
  • Well-established use application (Article 13a of Directive No 2001/82/EC)
Marketing authorisation holder:
  • Biopharm-Engineering AD
Marketing authorisation date:
Manufacturing sites for batch release:
  • Biopharm-Engineering AD
Responsible authority:
  • Bulgarian Agency For Food Safety
Authorisation number:
  • 0022-2949
Date of authorisation status change:

Documents

Summary of Product Characteristics

This document does not exist in this language (English). You can find it in another language below.
Bulgarian (PDF)
Published on: 6/08/2023
Download
How useful was this page?:
No votes yet
"Please do not include any personal data, such as your name or contact details. If you do, you consent to the processing of that data in accordance with EMA’s Privacy Statement concerning requests for information or access to documents. If you would like a reply from EMA, please Send a question to EMA instead."